OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
693457

Hcmed Innovations Co Ltd

Medical Equipment, Supplies & DistributionVerified

Capital Structure and Liquidity Hcmed Innovations Co Ltd has a basic and diluted share count of 32,717,000 shares outstanding, indicating no dilution from potential share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. ### Profitability and Returns The company's profitability and returns metrics are not available in the current dataset, making it difficult to compare with industry_config preferred metrics or cohort medians. Analysts have estimated a mean EPS of -3.01 TWD, suggesting a negative earnings outlook. ### Segments and Geographic Exposure There is no detailed information on the company's segments or geographic exposure in the provided data. The revenue concentration and segment performance remain undisclosed. ### Growth Trajectory Analysts have estimated a mean revenue of 139,000,000 TWD for the company, but no specific growth trajectory or numeric deltas are provided in the current dataset. ### Risk Factors The company faces low dilution risk, but liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in source documents. No specific risk factors or dilution sources are disclosed in the available data. ### Recent Events There are no recent events, filings, or transcripts provided in the dataset to inform the company's current status or strategic direction.

30-day price · 6934-12.60 (-14.8%)
Low$72.50High$100.00Close$72.50As of15 May, 00:00 UTC
Profile
CompanyHcmed Innovations Co Ltd
Ticker6934.TW
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Hcmed Innovations Co Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to the market.

Classification. The company is classified under the Healthcare Services & Equipment business sector and the Medical Equipment, Supplies & Distribution industry with a confidence level of 0.92.

### Capital Structure and Liquidity Hcmed Innovations Co Ltd has a basic and diluted share count of 32,717,000 shares outstanding, indicating no dilution from potential share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. ### Profitability and Returns The company's profitability and returns metrics are not available in the current dataset, making it difficult to compare with industry_config preferred metrics or cohort medians. Analysts have estimated a mean EPS of -3.01 TWD, suggesting a negative earnings outlook. ### Segments and Geographic Exposure There is no detailed information on the company's segments or geographic exposure in the provided data. The revenue concentration and segment performance remain undisclosed. ### Growth Trajectory Analysts have estimated a mean revenue of 139,000,000 TWD for the company, but no specific growth trajectory or numeric deltas are provided in the current dataset. ### Risk Factors The company faces low dilution risk, but liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in source documents. No specific risk factors or dilution sources are disclosed in the available data. ### Recent Events There are no recent events, filings, or transcripts provided in the dataset to inform the company's current status or strategic direction.
Key takeaways
  • Hcmed Innovations Co Ltd operates in the medical equipment, supplies, and distribution industry with a high classification confidence.
  • The company has no dilution from potential share issuance, with basic and diluted shares outstanding at 32,717,000.
  • Analysts have estimated a mean EPS of -3.01 TWD, indicating a negative earnings outlook.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • No detailed information is available on the company's segments, geographic exposure, or recent events.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$54.1M-$38.4M-$40.2M-$36.5M
FY-3$6.5M-$146.0M-$143.8M-$137.6M
FY-2$9.2M-$167.1M-$165.9M-$159.1M
FY-1$141.6M-$54.7M-$78.2M-$65.5M
FY0$100.2M-$131.5M-$126.1M-$161.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$89.2M-$172.3M$48.5M
FY-3$206.6M$181.0M$123.5M
FY-2$326.1M$277.0M$66.6M
FY-1$246.8M$209.3M$65.8M
FY0$441.2M$287.4M$138.5M
PeriodOCFCapExFCFSBC
FY-4-$19.8M-$5.3M-$36.5M
FY-3-$80.4M-$8.0M-$137.6M
FY-2-$111.6M-$16.4M-$159.1M
FY-1-$32.5M-$11.4M-$65.5M
FY0-$66.1M-$58.1M-$161.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2-$136.7M
FQ-1$6.9M-$37.1M-$36.1M-$31.7M
FQ0$82.5M$4.8M$7.0M$7.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2$370.1M$299.8M$57.4M
FQ-1$354.7M$266.8M$25.9M
FQ0$441.2M$287.4M$138.5M
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2-$77.0M-$51.4M-$136.7M
FQ-1-$104.3M-$52.4M-$31.7M
FQ0-$66.1M-$58.1M$7.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric6934Activity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Observations
IR observations
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-3.01 TWD
Mean revenue estimate139,000,000 TWD
Mean EBIT estimate-111,000,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:35 UTC#143ed6db
Market quoteclose TWD 78.10 · shares 0.03B diluted
no public URL
2026-05-10 10:35 UTC#2736c95b
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:32 UTCJob: 97aacea0